This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Buzzard Pharmaceuticals Ab, Hoffmann-La Roche Inc.. Active years: 2020-2024.
Company Filing History:
Years Active: 2020-2024
Title: Patricia Lowden: Innovator in Pharmaceutical Formulations
Introduction
Patricia Lowden is a notable inventor based in Hudson, MA (US), recognized for her contributions to pharmaceutical formulations. With a total of 2 patents, she has made significant strides in the field of medicine, particularly in the treatment of diseases associated with interleukin-6 (IL-6).
Latest Patents
Her latest patents include "IL-6 antagonist formulations and uses thereof," which features pharmaceutical compositions designed for administration to subjects. These formulations contain an IL-6 antagonist, such as an IL-6 antibody molecule, and are suitable for manufacturing medicaments aimed at treating IL-6 associated diseases, including ocular diseases linked to elevated IL-6 levels. Another significant patent is "Chimeric cytokine formulations for ocular delivery," which involves vehicle formulations containing a chimeric cytokine intended for ocular delivery.
Career Highlights
Throughout her career, Patricia has worked with prominent companies, including Hoffmann-La Roche Inc. and Buzzard Pharmaceuticals AB. Her experience in these organizations has contributed to her expertise in developing innovative pharmaceutical solutions.
Collaborations
Patricia has collaborated with notable individuals in her field, including Grigorios Zarbis-Papastoitsis and Gregory Zarbis-Papastoitsis. These collaborations have further enhanced her research and development efforts.
Conclusion
Patricia Lowden's work in pharmaceutical formulations showcases her dedication to advancing medical treatments. Her innovative patents reflect her commitment to addressing critical health issues, particularly those related to IL-6.